CDTX Historical PE Ratio image   This CDTX PE ratio history page last updated 11/7/2022
CDTX Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/3/2022
0.570.170.680.8
Q2 2022
8/9/2022
0.62-0.19-0.76NA
Q1 2022
5/11/2022
0.59-0.27-1.08NA
Q4 2021
3/7/2022
0.67-0.26-1.04NA
Q3 2021
11/10/2021
1.53-0.37-1.48NA
Q2 2021
8/12/2021
1.640.180.722.3
Q1 2021
5/13/2021
2.02-0.39-1.56NA
Q4 2020
2/25/2021
2.43-0.49-1.96NA
Q3 2020
11/5/2020
2.54-0.41-1.64NA
Q2 2020
8/13/2020
3.78-0.45-1.80NA
Q1 2020
5/13/2020
3.20-0.46-1.84NA
Q4 2019
3/4/2020
3.15-0.42-1.68NA
Q3 2019
11/7/2019
2.290.080.327.2
Q2 2019
8/8/2019
1.30-0.49-1.96NA
Q1 2019
5/9/2019
2.13-0.60-2.40NA
Q4 2018
2/28/2019
2.90-0.44-1.76NA
Q3 2018
11/8/2018
4.13-0.49-1.96NA
Q2 2018
8/8/2018
3.95-0.44-1.76NA
Q1 2018
5/10/2018
4.15-0.80-3.20NA
Q4 2017
2/27/2018
6.85-0.69-2.76NA
Q3 2017
11/8/2017
7.95-0.73-2.92NA
Q2 2017
8/9/2017
6.50-0.99-3.96NA
Q1 2017
5/10/2017
6.85-0.80-3.20NA
Q4 2016
3/15/2017
7.35-0.88-3.52NA
Q3 2016
11/10/2016
10.90-0.88-3.52NA
Q2 2016
8/11/2016
12.13-0.85-3.40NA
Q1 2016
5/12/2016
11.49-0.71-2.84NA
Q1 2015
5/21/2015
16.52-5.92-23.68NA
CDTX PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/3/2022
0.570.17-0.55NA
Q2 2022
8/9/2022
0.62-0.19-1.09NA
Q1 2022
5/11/2022
0.59-0.27-0.72NA
Q4 2021
3/7/2022
0.67-0.26-0.84NA
Q3 2021
11/10/2021
1.53-0.37-1.07NA
Q2 2021
8/12/2021
1.640.18-1.11NA
Q1 2021
5/13/2021
2.02-0.39-1.74NA
Q4 2020
2/25/2021
2.43-0.49-1.81NA
Q3 2020
11/5/2020
2.54-0.41-1.74NA
Q2 2020
8/13/2020
3.78-0.45-1.25NA
Q1 2020
5/13/2020
3.20-0.46-1.29NA
Q4 2019
3/4/2020
3.15-0.42-1.43NA
Q3 2019
11/7/2019
2.290.08-1.45NA
Q2 2019
8/8/2019
1.30-0.49-2.02NA
Q1 2019
5/9/2019
2.13-0.60-1.97NA
Q4 2018
2/28/2019
2.90-0.44-2.17NA
Q3 2018
11/8/2018
4.13-0.49-2.42NA
Q2 2018
8/8/2018
3.95-0.44-2.66NA
Q1 2018
5/10/2018
4.15-0.80-3.21NA
Q4 2017
2/27/2018
6.85-0.69-3.21NA
Q3 2017
11/8/2017
7.95-0.73-3.40NA
Q2 2017
8/9/2017
6.50-0.99-3.55NA
Q1 2017
5/10/2017
6.85-0.80-3.41NA
Q4 2016
3/15/2017
7.35-0.88-3.32NA
Q3 2016
11/10/2016
10.90-0.88-8.36NA
Q2 2016
8/11/2016
12.13-0.85NANA
Q1 2016
5/12/2016
11.49-0.71NANA
Q1 2015
5/21/2015
16.52-5.92NANA
Quotes delayed 20 minutes

Email EnvelopeFree CDTX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cidara Therapeutics (CDTX) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

CDXC PE Ratio History
CELC PE Ratio History
CEMI PE Ratio History
CERC PE Ratio History
CERE PE Ratio History
CERS PE Ratio History
CFMS PE Ratio History
CFRX PE Ratio History
CGEM PE Ratio History
CHE PE Ratio History
How should the CDTX historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Cidara Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this CDTX Historical PE Ratio page.

What is the average historical PE for CDTX based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The CDTX historical PE ratio using the annualized quarterly earnings method works out to 3.4.

What is the average historical PE for CDTX based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The CDTX historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the CDTX Historical PE Ratio information for Cidara Therapeutics' stock. The average CDTX historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 3.4. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average CDTX historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this CDTX historical PE result, against the recent PE: when this page was posted on 11/4/2022, the most recent closing price for CDTX had been 0.56, and the most recent quarterly earnings result, annualized, was 0.68. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent CDTX PE on 11/4/2022 based on annualized quarterly EPS was 0.8. Based on CDTX's history, that recent PE is low relative to the historical average, with the recent PE 76.5% lower than the historical average PE across our data set for Cidara Therapeutics.

For self directed investors doing their due diligence on CDTX or any other given stock, valuation analysis for CDTX can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Cidara Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for CDTX. Thanks for visiting, and the next time you need to research CDTX Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: BSF Insider Buying, Funds Holding GRUB, TWOA shares outstanding history.

 

CDTX Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.